0 CHECKOUT

Angola Pharmaceuticals and Healthcare Report Q2 2016

  • ID: 3615989
  • February 2016
  • Region: Angola
  • 49 pages
  • Business Monitor International
1 of 4

Angola is emerging from a long civil war, which has resulted in years of neglect of its healthcare sector. Whilst the government is taking positive measures to address a lack of hospitals and medical professionals via infrastructure projects, foreign investment in the healthcare sector and a fast growing population remain key growth factors for both pharmaceutical and healthcare markets. However, we believe uncertainty surrounding President Eduardo Jose Dos Santos' succession and the rise in civil unrest will dampen multinational drugmakers' interest in the market.

Headline Expenditure Forecasts

- Pharmaceuticals: AOA34.25bn (USD282mn) in 2015 to AOA36.70bn (USD252mn) in 2016; +7.1% in local currency and -10.7% in US dollar terms.

- Healthcare: AOA640.83bn (USD5.28bn) in 2015 to AOA703.14bn (USD4.83bn) in 2016; +9.7% in local currency and -8.5% in US dollar terms.

Note: Product cover images may vary from those shown
2 of 4

- Industry View

- Table: Headline Pharmaceuticals & Healthcare Forecasts (Angola 2014-2020)

- SWOT

- Industry Forecast

- Pharmaceutical Market Forecast

- Table: Pharmaceutical Sales, Historical Data And Forecasts (Angola 2012-2020)

- Healthcare Market Forecast

- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Angola 2012-2020)

- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Angola 2012-2020)

- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Angola 2012-2020)

- Industry Risk/Reward Index

- Middle East and Africa Risk/Reward Index - Q2 2016

- Angola Risk/Reward Index

- Rewards

- Risks

- Regulatory Review

- Intellectual Property Issues

- Pricing Regime

- Market Overview

- Healthcare Sector

- Clinical Trials

- Epidemiology

- Competitive Landscape

- Company Profile

- Nova Angomédica

- Demographic Forecast

- Table: Population Headline Indicators (Angola 1990-2025)

- Table: Key Population Ratios (Angola 1990-2025)

- Table: Urban/Rural Population & Life Expectancy (Angola 1990-2025)

- Table: Population By Age Group (Angola 1990-2025)

- Table: Population By Age Group % (Angola 1990-2025)

- Glossary

- Methodology

- Pharmaceutical Expenditure Forecast Model

- Healthcare Expenditure Forecast Model

- Notes On Methodology

- Risk/Reward Index Methodology

- Index Overview

- Table: Pharmaceutical Risk/Reward Index Indicators

- Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

- Nova Angomédica

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S